Kaisa Tuppurainen
- Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPDBy Heikki Ekroos, Jarmo Hahl, Kaisa Tuppurainen, Kari Linden, Miika Linna and Harri SintonenHeikki Ekroos1Porvoo Hospital, Hospital District of Helsinki and Uusimaa, Porvoo, FinlandJarmo Hahl2Market Access and Health Outcomes, AT Medical Affairs Consulting (Medaffcon) Oy, Espoo, FinlandKaisa Tuppurainen3Medical Department, Pfizer Oy, Helsinki, FinlandKari Linden3Medical Department, Pfizer Oy, Helsinki, FinlandMiika Linna4HEMA institute/Department of Industrial Engineering and Management, Aalto University and National Institute for Health and Welfare, Helsinki, FinlandHarri Sintonen5Hjelt Institute/Department of Public Health, University of Helsinki, Finland
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.